nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—ABCB1—melanoma	0.395	1	CbGaD
Reboxetine—CYP3A4—Temozolomide—melanoma	0.109	0.284	CbGbCtD
Reboxetine—CYP2D6—Vemurafenib—melanoma	0.0938	0.245	CbGbCtD
Reboxetine—ABCB1—Dactinomycin—melanoma	0.0662	0.173	CbGbCtD
Reboxetine—CYP3A4—Vemurafenib—melanoma	0.0597	0.156	CbGbCtD
Reboxetine—ABCB1—Docetaxel—melanoma	0.0342	0.0892	CbGbCtD
Reboxetine—CYP3A4—Docetaxel—melanoma	0.0205	0.0534	CbGbCtD
Reboxetine—Dysgeusia—Vemurafenib—melanoma	0.00109	0.00606	CcSEcCtD
Reboxetine—Myocardial ischaemia—Docetaxel—melanoma	0.00107	0.00598	CcSEcCtD
Reboxetine—Gastroenteritis—Temozolomide—melanoma	0.00106	0.00592	CcSEcCtD
Reboxetine—Amenorrhoea—Docetaxel—melanoma	0.000982	0.00547	CcSEcCtD
Reboxetine—Hyponatraemia—Carmustine—melanoma	0.000979	0.00545	CcSEcCtD
Reboxetine—Diplopia—Carmustine—melanoma	0.000975	0.00543	CcSEcCtD
Reboxetine—Liver function test abnormal—Dactinomycin—melanoma	0.000962	0.00536	CcSEcCtD
Reboxetine—Diplopia—Temozolomide—melanoma	0.000942	0.00525	CcSEcCtD
Reboxetine—Face oedema—Carmustine—melanoma	0.000941	0.00524	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000939	0.00523	CcSEcCtD
Reboxetine—Face oedema—Temozolomide—melanoma	0.00091	0.00507	CcSEcCtD
Reboxetine—Infection—Vemurafenib—melanoma	0.0009	0.00502	CcSEcCtD
Reboxetine—Liver function test abnormal—Carmustine—melanoma	0.0009	0.00502	CcSEcCtD
Reboxetine—Nervous system disorder—Vemurafenib—melanoma	0.000889	0.00495	CcSEcCtD
Reboxetine—Skin disorder—Vemurafenib—melanoma	0.00088	0.0049	CcSEcCtD
Reboxetine—Respiratory failure—Docetaxel—melanoma	0.000879	0.0049	CcSEcCtD
Reboxetine—Dehydration—Temozolomide—melanoma	0.000876	0.00488	CcSEcCtD
Reboxetine—Weight decreased—Bleomycin—melanoma	0.000873	0.00487	CcSEcCtD
Reboxetine—Muscular weakness—Carmustine—melanoma	0.00086	0.00479	CcSEcCtD
Reboxetine—Breast disorder—Temozolomide—melanoma	0.000851	0.00474	CcSEcCtD
Reboxetine—Hypotension—Vemurafenib—melanoma	0.000847	0.00472	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Temozolomide—melanoma	0.000831	0.00463	CcSEcCtD
Reboxetine—Muscular weakness—Temozolomide—melanoma	0.000831	0.00463	CcSEcCtD
Reboxetine—Decreased appetite—Vemurafenib—melanoma	0.000788	0.00439	CcSEcCtD
Reboxetine—Bronchitis—Temozolomide—melanoma	0.000783	0.00436	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Vemurafenib—melanoma	0.000782	0.00436	CcSEcCtD
Reboxetine—Constipation—Vemurafenib—melanoma	0.000775	0.00432	CcSEcCtD
Reboxetine—Dysuria—Temozolomide—melanoma	0.000762	0.00424	CcSEcCtD
Reboxetine—Hyperglycaemia—Carmustine—melanoma	0.00076	0.00424	CcSEcCtD
Reboxetine—Pollakiuria—Temozolomide—melanoma	0.000752	0.00419	CcSEcCtD
Reboxetine—Erectile dysfunction—Temozolomide—melanoma	0.00075	0.00418	CcSEcCtD
Reboxetine—Weight decreased—Temozolomide—melanoma	0.000737	0.0041	CcSEcCtD
Reboxetine—Hyperglycaemia—Temozolomide—melanoma	0.000735	0.00409	CcSEcCtD
Reboxetine—Urinary tract infection—Carmustine—melanoma	0.00073	0.00407	CcSEcCtD
Reboxetine—Infestation NOS—Temozolomide—melanoma	0.000726	0.00405	CcSEcCtD
Reboxetine—Infestation—Temozolomide—melanoma	0.000726	0.00405	CcSEcCtD
Reboxetine—Body temperature increased—Vemurafenib—melanoma	0.000716	0.00399	CcSEcCtD
Reboxetine—Pharyngitis—Dactinomycin—melanoma	0.000715	0.00399	CcSEcCtD
Reboxetine—Urinary tract infection—Temozolomide—melanoma	0.000706	0.00393	CcSEcCtD
Reboxetine—Chills—Bleomycin—melanoma	0.000693	0.00386	CcSEcCtD
Reboxetine—Sinusitis—Temozolomide—melanoma	0.000681	0.0038	CcSEcCtD
Reboxetine—Hallucination—Carmustine—melanoma	0.000671	0.00374	CcSEcCtD
Reboxetine—Hypersensitivity—Vemurafenib—melanoma	0.000668	0.00372	CcSEcCtD
Reboxetine—Connective tissue disorder—Carmustine—melanoma	0.000663	0.00369	CcSEcCtD
Reboxetine—Asthenia—Vemurafenib—melanoma	0.00065	0.00362	CcSEcCtD
Reboxetine—Visual impairment—Carmustine—melanoma	0.00065	0.00362	CcSEcCtD
Reboxetine—Hallucination—Temozolomide—melanoma	0.000649	0.00361	CcSEcCtD
Reboxetine—Pharyngitis—Temozolomide—melanoma	0.000647	0.0036	CcSEcCtD
Reboxetine—Chills—Dactinomycin—melanoma	0.000647	0.0036	CcSEcCtD
Reboxetine—Urinary tract disorder—Temozolomide—melanoma	0.000644	0.00359	CcSEcCtD
Reboxetine—Connective tissue disorder—Temozolomide—melanoma	0.000641	0.00357	CcSEcCtD
Reboxetine—Urethral disorder—Temozolomide—melanoma	0.000639	0.00356	CcSEcCtD
Reboxetine—Eye disorder—Carmustine—melanoma	0.00063	0.00351	CcSEcCtD
Reboxetine—Hyponatraemia—Docetaxel—melanoma	0.000629	0.00351	CcSEcCtD
Reboxetine—Visual impairment—Temozolomide—melanoma	0.000628	0.0035	CcSEcCtD
Reboxetine—Ill-defined disorder—Bleomycin—melanoma	0.000624	0.00348	CcSEcCtD
Reboxetine—Anaemia—Bleomycin—melanoma	0.000622	0.00346	CcSEcCtD
Reboxetine—Diarrhoea—Vemurafenib—melanoma	0.00062	0.00345	CcSEcCtD
Reboxetine—Eye disorder—Temozolomide—melanoma	0.000609	0.00339	CcSEcCtD
Reboxetine—Tinnitus—Temozolomide—melanoma	0.000608	0.00339	CcSEcCtD
Reboxetine—Malaise—Bleomycin—melanoma	0.000607	0.00338	CcSEcCtD
Reboxetine—Cardiac disorder—Temozolomide—melanoma	0.000605	0.00337	CcSEcCtD
Reboxetine—Leukopenia—Bleomycin—melanoma	0.000602	0.00335	CcSEcCtD
Reboxetine—Dizziness—Vemurafenib—melanoma	0.000599	0.00334	CcSEcCtD
Reboxetine—Angiopathy—Temozolomide—melanoma	0.000591	0.0033	CcSEcCtD
Reboxetine—Mental disorder—Carmustine—melanoma	0.000591	0.00329	CcSEcCtD
Reboxetine—Immune system disorder—Temozolomide—melanoma	0.000589	0.00328	CcSEcCtD
Reboxetine—Mediastinal disorder—Temozolomide—melanoma	0.000587	0.00327	CcSEcCtD
Reboxetine—Malnutrition—Carmustine—melanoma	0.000587	0.00327	CcSEcCtD
Reboxetine—Chills—Temozolomide—melanoma	0.000585	0.00326	CcSEcCtD
Reboxetine—Dehydration—Docetaxel—melanoma	0.000583	0.00325	CcSEcCtD
Reboxetine—Ill-defined disorder—Dactinomycin—melanoma	0.000582	0.00324	CcSEcCtD
Reboxetine—Anaemia—Dactinomycin—melanoma	0.00058	0.00323	CcSEcCtD
Reboxetine—Liver function test abnormal—Docetaxel—melanoma	0.000579	0.00322	CcSEcCtD
Reboxetine—Vomiting—Vemurafenib—melanoma	0.000576	0.00321	CcSEcCtD
Reboxetine—Chest pain—Bleomycin—melanoma	0.000573	0.00319	CcSEcCtD
Reboxetine—Orthostatic hypotension—Docetaxel—melanoma	0.000572	0.00319	CcSEcCtD
Reboxetine—Rash—Vemurafenib—melanoma	0.000571	0.00318	CcSEcCtD
Reboxetine—Mental disorder—Temozolomide—melanoma	0.000571	0.00318	CcSEcCtD
Reboxetine—Dermatitis—Vemurafenib—melanoma	0.000571	0.00318	CcSEcCtD
Reboxetine—Headache—Vemurafenib—melanoma	0.000568	0.00316	CcSEcCtD
Reboxetine—Malnutrition—Temozolomide—melanoma	0.000567	0.00316	CcSEcCtD
Reboxetine—Breast disorder—Docetaxel—melanoma	0.000566	0.00315	CcSEcCtD
Reboxetine—Discomfort—Bleomycin—melanoma	0.000566	0.00315	CcSEcCtD
Reboxetine—Malaise—Dactinomycin—melanoma	0.000566	0.00315	CcSEcCtD
Reboxetine—Leukopenia—Dactinomycin—melanoma	0.000562	0.00313	CcSEcCtD
Reboxetine—Dysgeusia—Temozolomide—melanoma	0.000556	0.0031	CcSEcCtD
Reboxetine—Confusional state—Bleomycin—melanoma	0.000554	0.00308	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Docetaxel—melanoma	0.000553	0.00308	CcSEcCtD
Reboxetine—Tremor—Carmustine—melanoma	0.00055	0.00307	CcSEcCtD
Reboxetine—Infection—Bleomycin—melanoma	0.000545	0.00304	CcSEcCtD
Reboxetine—Anaemia—Carmustine—melanoma	0.000543	0.00302	CcSEcCtD
Reboxetine—Agitation—Carmustine—melanoma	0.00054	0.00301	CcSEcCtD
Reboxetine—Nausea—Vemurafenib—melanoma	0.000538	0.003	CcSEcCtD
Reboxetine—Tremor—Temozolomide—melanoma	0.000532	0.00296	CcSEcCtD
Reboxetine—Discomfort—Dactinomycin—melanoma	0.000528	0.00294	CcSEcCtD
Reboxetine—Ill-defined disorder—Temozolomide—melanoma	0.000526	0.00293	CcSEcCtD
Reboxetine—Leukopenia—Carmustine—melanoma	0.000526	0.00293	CcSEcCtD
Reboxetine—Anaemia—Temozolomide—melanoma	0.000524	0.00292	CcSEcCtD
Reboxetine—Anorexia—Bleomycin—melanoma	0.000523	0.00292	CcSEcCtD
Reboxetine—Agitation—Temozolomide—melanoma	0.000521	0.00291	CcSEcCtD
Reboxetine—Hypotension—Bleomycin—melanoma	0.000513	0.00286	CcSEcCtD
Reboxetine—Malaise—Temozolomide—melanoma	0.000512	0.00285	CcSEcCtD
Reboxetine—Vertigo—Temozolomide—melanoma	0.00051	0.00284	CcSEcCtD
Reboxetine—Infection—Dactinomycin—melanoma	0.000509	0.00283	CcSEcCtD
Reboxetine—Leukopenia—Temozolomide—melanoma	0.000508	0.00283	CcSEcCtD
Reboxetine—Hypertension—Carmustine—melanoma	0.000507	0.00282	CcSEcCtD
Reboxetine—Palpitations—Temozolomide—melanoma	0.000501	0.00279	CcSEcCtD
Reboxetine—Chest pain—Carmustine—melanoma	0.0005	0.00279	CcSEcCtD
Reboxetine—Anxiety—Carmustine—melanoma	0.000498	0.00278	CcSEcCtD
Reboxetine—Paraesthesia—Bleomycin—melanoma	0.000493	0.00275	CcSEcCtD
Reboxetine—Weight decreased—Docetaxel—melanoma	0.00049	0.00273	CcSEcCtD
Reboxetine—Hypertension—Temozolomide—melanoma	0.00049	0.00273	CcSEcCtD
Reboxetine—Dyspnoea—Bleomycin—melanoma	0.000489	0.00273	CcSEcCtD
Reboxetine—Anorexia—Dactinomycin—melanoma	0.000488	0.00272	CcSEcCtD
Reboxetine—Confusional state—Carmustine—melanoma	0.000483	0.00269	CcSEcCtD
Reboxetine—Infestation—Docetaxel—melanoma	0.000483	0.00269	CcSEcCtD
Reboxetine—Infestation NOS—Docetaxel—melanoma	0.000483	0.00269	CcSEcCtD
Reboxetine—Anxiety—Temozolomide—melanoma	0.000481	0.00268	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00048	0.00267	CcSEcCtD
Reboxetine—Discomfort—Temozolomide—melanoma	0.000477	0.00266	CcSEcCtD
Reboxetine—Decreased appetite—Bleomycin—melanoma	0.000477	0.00266	CcSEcCtD
Reboxetine—Infection—Carmustine—melanoma	0.000476	0.00265	CcSEcCtD
Reboxetine—Dry mouth—Temozolomide—melanoma	0.000472	0.00263	CcSEcCtD
Reboxetine—Conjunctivitis—Docetaxel—melanoma	0.000469	0.00262	CcSEcCtD
Reboxetine—Tachycardia—Carmustine—melanoma	0.000468	0.00261	CcSEcCtD
Reboxetine—Confusional state—Temozolomide—melanoma	0.000467	0.0026	CcSEcCtD
Reboxetine—Infection—Temozolomide—melanoma	0.00046	0.00256	CcSEcCtD
Reboxetine—Anorexia—Carmustine—melanoma	0.000457	0.00255	CcSEcCtD
Reboxetine—Epistaxis—Docetaxel—melanoma	0.000455	0.00254	CcSEcCtD
Reboxetine—Nervous system disorder—Temozolomide—melanoma	0.000454	0.00253	CcSEcCtD
Reboxetine—Feeling abnormal—Bleomycin—melanoma	0.000452	0.00252	CcSEcCtD
Reboxetine—Skin disorder—Temozolomide—melanoma	0.00045	0.00251	CcSEcCtD
Reboxetine—Hypotension—Carmustine—melanoma	0.000448	0.00249	CcSEcCtD
Reboxetine—Hyperhidrosis—Temozolomide—melanoma	0.000448	0.00249	CcSEcCtD
Reboxetine—Decreased appetite—Dactinomycin—melanoma	0.000445	0.00248	CcSEcCtD
Reboxetine—Anorexia—Temozolomide—melanoma	0.000441	0.00246	CcSEcCtD
Reboxetine—Urticaria—Bleomycin—melanoma	0.000436	0.00243	CcSEcCtD
Reboxetine—Rhinitis—Docetaxel—melanoma	0.000435	0.00242	CcSEcCtD
Reboxetine—Body temperature increased—Bleomycin—melanoma	0.000434	0.00242	CcSEcCtD
Reboxetine—Insomnia—Carmustine—melanoma	0.000433	0.00241	CcSEcCtD
Reboxetine—Paraesthesia—Carmustine—melanoma	0.00043	0.0024	CcSEcCtD
Reboxetine—Pharyngitis—Docetaxel—melanoma	0.00043	0.0024	CcSEcCtD
Reboxetine—Urinary tract disorder—Docetaxel—melanoma	0.000428	0.00239	CcSEcCtD
Reboxetine—Dyspnoea—Carmustine—melanoma	0.000427	0.00238	CcSEcCtD
Reboxetine—Somnolence—Carmustine—melanoma	0.000426	0.00237	CcSEcCtD
Reboxetine—Connective tissue disorder—Docetaxel—melanoma	0.000426	0.00237	CcSEcCtD
Reboxetine—Urethral disorder—Docetaxel—melanoma	0.000425	0.00237	CcSEcCtD
Reboxetine—Feeling abnormal—Dactinomycin—melanoma	0.000422	0.00235	CcSEcCtD
Reboxetine—Insomnia—Temozolomide—melanoma	0.000419	0.00233	CcSEcCtD
Reboxetine—Gastrointestinal pain—Dactinomycin—melanoma	0.000419	0.00233	CcSEcCtD
Reboxetine—Visual impairment—Docetaxel—melanoma	0.000418	0.00233	CcSEcCtD
Reboxetine—Decreased appetite—Carmustine—melanoma	0.000417	0.00232	CcSEcCtD
Reboxetine—Paraesthesia—Temozolomide—melanoma	0.000416	0.00232	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Carmustine—melanoma	0.000414	0.00231	CcSEcCtD
Reboxetine—Dyspnoea—Temozolomide—melanoma	0.000413	0.0023	CcSEcCtD
Reboxetine—Somnolence—Temozolomide—melanoma	0.000412	0.00229	CcSEcCtD
Reboxetine—Constipation—Carmustine—melanoma	0.00041	0.00228	CcSEcCtD
Reboxetine—Dyspepsia—Temozolomide—melanoma	0.000408	0.00227	CcSEcCtD
Reboxetine—Eye disorder—Docetaxel—melanoma	0.000405	0.00226	CcSEcCtD
Reboxetine—Abdominal pain—Dactinomycin—melanoma	0.000405	0.00226	CcSEcCtD
Reboxetine—Body temperature increased—Dactinomycin—melanoma	0.000405	0.00226	CcSEcCtD
Reboxetine—Hypersensitivity—Bleomycin—melanoma	0.000404	0.00225	CcSEcCtD
Reboxetine—Decreased appetite—Temozolomide—melanoma	0.000403	0.00224	CcSEcCtD
Reboxetine—Cardiac disorder—Docetaxel—melanoma	0.000402	0.00224	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Temozolomide—melanoma	0.0004	0.00223	CcSEcCtD
Reboxetine—Constipation—Temozolomide—melanoma	0.000396	0.00221	CcSEcCtD
Reboxetine—Feeling abnormal—Carmustine—melanoma	0.000395	0.0022	CcSEcCtD
Reboxetine—Asthenia—Bleomycin—melanoma	0.000394	0.00219	CcSEcCtD
Reboxetine—Angiopathy—Docetaxel—melanoma	0.000393	0.00219	CcSEcCtD
Reboxetine—Gastrointestinal pain—Carmustine—melanoma	0.000392	0.00218	CcSEcCtD
Reboxetine—Immune system disorder—Docetaxel—melanoma	0.000392	0.00218	CcSEcCtD
Reboxetine—Mediastinal disorder—Docetaxel—melanoma	0.000391	0.00218	CcSEcCtD
Reboxetine—Chills—Docetaxel—melanoma	0.000389	0.00217	CcSEcCtD
Reboxetine—Feeling abnormal—Temozolomide—melanoma	0.000382	0.00213	CcSEcCtD
Reboxetine—Mental disorder—Docetaxel—melanoma	0.00038	0.00212	CcSEcCtD
Reboxetine—Abdominal pain—Carmustine—melanoma	0.000379	0.00211	CcSEcCtD
Reboxetine—Body temperature increased—Carmustine—melanoma	0.000379	0.00211	CcSEcCtD
Reboxetine—Gastrointestinal pain—Temozolomide—melanoma	0.000379	0.00211	CcSEcCtD
Reboxetine—Malnutrition—Docetaxel—melanoma	0.000377	0.0021	CcSEcCtD
Reboxetine—Hypersensitivity—Dactinomycin—melanoma	0.000377	0.0021	CcSEcCtD
Reboxetine—Dysgeusia—Docetaxel—melanoma	0.00037	0.00206	CcSEcCtD
Reboxetine—Urticaria—Temozolomide—melanoma	0.000368	0.00205	CcSEcCtD
Reboxetine—Asthenia—Dactinomycin—melanoma	0.000367	0.00205	CcSEcCtD
Reboxetine—Body temperature increased—Temozolomide—melanoma	0.000366	0.00204	CcSEcCtD
Reboxetine—Abdominal pain—Temozolomide—melanoma	0.000366	0.00204	CcSEcCtD
Reboxetine—Hypersensitivity—Carmustine—melanoma	0.000353	0.00197	CcSEcCtD
Reboxetine—Diarrhoea—Dactinomycin—melanoma	0.00035	0.00195	CcSEcCtD
Reboxetine—Vomiting—Bleomycin—melanoma	0.000349	0.00194	CcSEcCtD
Reboxetine—Anaemia—Docetaxel—melanoma	0.000349	0.00194	CcSEcCtD
Reboxetine—Rash—Bleomycin—melanoma	0.000346	0.00193	CcSEcCtD
Reboxetine—Dermatitis—Bleomycin—melanoma	0.000346	0.00193	CcSEcCtD
Reboxetine—Asthenia—Carmustine—melanoma	0.000344	0.00192	CcSEcCtD
Reboxetine—Hypersensitivity—Temozolomide—melanoma	0.000341	0.0019	CcSEcCtD
Reboxetine—Syncope—Docetaxel—melanoma	0.000338	0.00189	CcSEcCtD
Reboxetine—Leukopenia—Docetaxel—melanoma	0.000338	0.00188	CcSEcCtD
Reboxetine—Palpitations—Docetaxel—melanoma	0.000333	0.00186	CcSEcCtD
Reboxetine—Asthenia—Temozolomide—melanoma	0.000332	0.00185	CcSEcCtD
Reboxetine—Loss of consciousness—Docetaxel—melanoma	0.000332	0.00185	CcSEcCtD
Reboxetine—Diarrhoea—Carmustine—melanoma	0.000328	0.00183	CcSEcCtD
Reboxetine—Nausea—Bleomycin—melanoma	0.000326	0.00182	CcSEcCtD
Reboxetine—Hypertension—Docetaxel—melanoma	0.000326	0.00182	CcSEcCtD
Reboxetine—Vomiting—Dactinomycin—melanoma	0.000326	0.00181	CcSEcCtD
Reboxetine—Rash—Dactinomycin—melanoma	0.000323	0.0018	CcSEcCtD
Reboxetine—Chest pain—Docetaxel—melanoma	0.000321	0.00179	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000319	0.00178	CcSEcCtD
Reboxetine—Dizziness—Carmustine—melanoma	0.000317	0.00177	CcSEcCtD
Reboxetine—Diarrhoea—Temozolomide—melanoma	0.000317	0.00177	CcSEcCtD
Reboxetine—Dry mouth—Docetaxel—melanoma	0.000314	0.00175	CcSEcCtD
Reboxetine—Confusional state—Docetaxel—melanoma	0.000311	0.00173	CcSEcCtD
Reboxetine—Dizziness—Temozolomide—melanoma	0.000306	0.00171	CcSEcCtD
Reboxetine—Infection—Docetaxel—melanoma	0.000306	0.0017	CcSEcCtD
Reboxetine—Vomiting—Carmustine—melanoma	0.000305	0.0017	CcSEcCtD
Reboxetine—Nausea—Dactinomycin—melanoma	0.000304	0.00169	CcSEcCtD
Reboxetine—Shock—Docetaxel—melanoma	0.000303	0.00169	CcSEcCtD
Reboxetine—Rash—Carmustine—melanoma	0.000302	0.00168	CcSEcCtD
Reboxetine—Nervous system disorder—Docetaxel—melanoma	0.000302	0.00168	CcSEcCtD
Reboxetine—Dermatitis—Carmustine—melanoma	0.000302	0.00168	CcSEcCtD
Reboxetine—Tachycardia—Docetaxel—melanoma	0.000301	0.00167	CcSEcCtD
Reboxetine—Headache—Carmustine—melanoma	0.0003	0.00167	CcSEcCtD
Reboxetine—Skin disorder—Docetaxel—melanoma	0.000299	0.00167	CcSEcCtD
Reboxetine—Vomiting—Temozolomide—melanoma	0.000294	0.00164	CcSEcCtD
Reboxetine—Anorexia—Docetaxel—melanoma	0.000294	0.00164	CcSEcCtD
Reboxetine—Rash—Temozolomide—melanoma	0.000292	0.00163	CcSEcCtD
Reboxetine—Dermatitis—Temozolomide—melanoma	0.000292	0.00163	CcSEcCtD
Reboxetine—Headache—Temozolomide—melanoma	0.00029	0.00162	CcSEcCtD
Reboxetine—Hypotension—Docetaxel—melanoma	0.000288	0.0016	CcSEcCtD
Reboxetine—Nausea—Carmustine—melanoma	0.000285	0.00159	CcSEcCtD
Reboxetine—Insomnia—Docetaxel—melanoma	0.000279	0.00155	CcSEcCtD
Reboxetine—Paraesthesia—Docetaxel—melanoma	0.000277	0.00154	CcSEcCtD
Reboxetine—Nausea—Temozolomide—melanoma	0.000275	0.00153	CcSEcCtD
Reboxetine—Dyspnoea—Docetaxel—melanoma	0.000275	0.00153	CcSEcCtD
Reboxetine—Somnolence—Docetaxel—melanoma	0.000274	0.00153	CcSEcCtD
Reboxetine—Dyspepsia—Docetaxel—melanoma	0.000271	0.00151	CcSEcCtD
Reboxetine—Decreased appetite—Docetaxel—melanoma	0.000268	0.00149	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Docetaxel—melanoma	0.000266	0.00148	CcSEcCtD
Reboxetine—Constipation—Docetaxel—melanoma	0.000263	0.00147	CcSEcCtD
Reboxetine—Feeling abnormal—Docetaxel—melanoma	0.000254	0.00141	CcSEcCtD
Reboxetine—Gastrointestinal pain—Docetaxel—melanoma	0.000252	0.0014	CcSEcCtD
Reboxetine—Abdominal pain—Docetaxel—melanoma	0.000243	0.00136	CcSEcCtD
Reboxetine—Body temperature increased—Docetaxel—melanoma	0.000243	0.00136	CcSEcCtD
Reboxetine—Hypersensitivity—Docetaxel—melanoma	0.000227	0.00126	CcSEcCtD
Reboxetine—Asthenia—Docetaxel—melanoma	0.000221	0.00123	CcSEcCtD
Reboxetine—Diarrhoea—Docetaxel—melanoma	0.000211	0.00117	CcSEcCtD
Reboxetine—Dizziness—Docetaxel—melanoma	0.000204	0.00113	CcSEcCtD
Reboxetine—Vomiting—Docetaxel—melanoma	0.000196	0.00109	CcSEcCtD
Reboxetine—Rash—Docetaxel—melanoma	0.000194	0.00108	CcSEcCtD
Reboxetine—Dermatitis—Docetaxel—melanoma	0.000194	0.00108	CcSEcCtD
Reboxetine—Headache—Docetaxel—melanoma	0.000193	0.00107	CcSEcCtD
Reboxetine—Nausea—Docetaxel—melanoma	0.000183	0.00102	CcSEcCtD
Reboxetine—HTR2C—Signaling Pathways—SKI—melanoma	2.65e-05	0.000634	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CXCR1—melanoma	2.65e-05	0.000634	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MC1R—melanoma	2.61e-05	0.000624	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—PIK3CA—melanoma	2.61e-05	0.000623	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—AKT3—melanoma	2.58e-05	0.000617	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CXCR4—melanoma	2.57e-05	0.000614	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—GNAQ—melanoma	2.54e-05	0.000607	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—melanoma	2.54e-05	0.000607	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	2.53e-05	0.000603	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GRM1—melanoma	2.51e-05	0.000598	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCR7—melanoma	2.51e-05	0.000598	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SUFU—melanoma	2.44e-05	0.000583	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	2.4e-05	0.000573	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	2.36e-05	0.000565	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PLCB4—melanoma	2.36e-05	0.000564	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—ALB—melanoma	2.35e-05	0.000561	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—AKT3—melanoma	2.35e-05	0.00056	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—melanoma	2.34e-05	0.000558	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	2.33e-05	0.000557	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—BCL2L11—melanoma	2.28e-05	0.000544	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—RHOB—melanoma	2.28e-05	0.000544	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	2.28e-05	0.000544	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ACER3—melanoma	2.26e-05	0.000539	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PLCB4—melanoma	2.23e-05	0.000532	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SLC6A11—melanoma	2.22e-05	0.00053	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIP4K2A—melanoma	2.22e-05	0.00053	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HDAC6—melanoma	2.19e-05	0.000523	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—EDN1—melanoma	2.17e-05	0.000518	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	2.17e-05	0.000518	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—MTAP—melanoma	2.16e-05	0.000516	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—melanoma	2.16e-05	0.000516	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	2.16e-05	0.000515	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—CSF2—melanoma	2.12e-05	0.000506	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	2.12e-05	0.000505	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIP4K2A—melanoma	2.09e-05	0.0005	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SLC6A11—melanoma	2.09e-05	0.0005	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CXCR2—melanoma	2.08e-05	0.000496	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—CXCL8—melanoma	2.08e-05	0.000496	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—melanoma	2.07e-05	0.000494	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—UGT2B10—melanoma	2.07e-05	0.000493	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	2.06e-05	0.000492	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—RAC2—melanoma	2.04e-05	0.000488	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	2.04e-05	0.000487	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MTAP—melanoma	2.04e-05	0.000486	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PRKCA—melanoma	2.03e-05	0.000486	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—VEGFC—melanoma	2.01e-05	0.00048	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—WNT5A—melanoma	2.01e-05	0.00048	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	1.99e-05	0.000476	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	1.99e-05	0.000475	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	1.98e-05	0.000472	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—EDN1—melanoma	1.97e-05	0.000471	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CSF2—melanoma	1.93e-05	0.00046	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—LUM—melanoma	1.93e-05	0.00046	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PHGDH—melanoma	1.93e-05	0.00046	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HS3ST5—melanoma	1.92e-05	0.000459	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—HPSE—melanoma	1.89e-05	0.000451	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—RAC1—melanoma	1.89e-05	0.00045	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CUBN—melanoma	1.85e-05	0.000443	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PRKCA—melanoma	1.85e-05	0.000441	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—LUM—melanoma	1.82e-05	0.000433	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PHGDH—melanoma	1.82e-05	0.000433	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—MAP2K2—melanoma	1.81e-05	0.000431	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.8e-05	0.000429	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SDHD—melanoma	1.79e-05	0.000427	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—BSG—melanoma	1.79e-05	0.000427	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CSPG4—melanoma	1.79e-05	0.000427	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—HPSE—melanoma	1.78e-05	0.000425	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—F2R—melanoma	1.77e-05	0.000422	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CUBN—melanoma	1.75e-05	0.000417	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GPAM—melanoma	1.73e-05	0.000414	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—RAC1—melanoma	1.71e-05	0.000409	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—EDNRB—melanoma	1.71e-05	0.000408	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.7e-05	0.000406	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—BSG—melanoma	1.69e-05	0.000403	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CSPG4—melanoma	1.69e-05	0.000403	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SDHD—melanoma	1.69e-05	0.000403	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PTK2B—melanoma	1.66e-05	0.000396	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.65e-05	0.000394	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GPAM—melanoma	1.63e-05	0.00039	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.62e-05	0.000386	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.62e-05	0.000386	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GNA11—melanoma	1.62e-05	0.000386	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GAB2—melanoma	1.62e-05	0.000386	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FLT1—melanoma	1.61e-05	0.000384	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PIK3CG—melanoma	1.59e-05	0.00038	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.54e-05	0.000367	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.53e-05	0.000364	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CXCR4—melanoma	1.52e-05	0.000363	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HDAC2—melanoma	1.52e-05	0.000363	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FOXO4—melanoma	1.52e-05	0.000363	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—GNAQ—melanoma	1.5e-05	0.000359	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PLA2G6—melanoma	1.47e-05	0.000352	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PLCB4—melanoma	1.46e-05	0.000348	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PIK3CG—melanoma	1.45e-05	0.000345	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SYK—melanoma	1.41e-05	0.000337	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.4e-05	0.000335	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PIK3CD—melanoma	1.4e-05	0.000334	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PLA2G6—melanoma	1.39e-05	0.000332	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NGFR—melanoma	1.39e-05	0.000331	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ITGAV—melanoma	1.39e-05	0.000331	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AKT3—melanoma	1.39e-05	0.000331	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIP4K2A—melanoma	1.37e-05	0.000327	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLC6A11—melanoma	1.37e-05	0.000327	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.36e-05	0.000324	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MTAP—melanoma	1.33e-05	0.000318	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—VCAN—melanoma	1.32e-05	0.000316	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SOCS1—melanoma	1.28e-05	0.000306	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—MAP2K1—melanoma	1.28e-05	0.000306	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—S100B—melanoma	1.28e-05	0.000306	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PIK3CD—melanoma	1.27e-05	0.000304	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—VCAN—melanoma	1.25e-05	0.000298	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ERBB4—melanoma	1.22e-05	0.000292	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PIK3CB—melanoma	1.22e-05	0.000291	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CDKN2B—melanoma	1.21e-05	0.00029	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—LUM—melanoma	1.19e-05	0.000283	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PHGDH—melanoma	1.19e-05	0.000283	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CD86—melanoma	1.17e-05	0.00028	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—CXCL8—melanoma	1.17e-05	0.00028	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—EDN1—melanoma	1.16e-05	0.000278	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—HPSE—melanoma	1.16e-05	0.000278	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.15e-05	0.000274	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CUBN—melanoma	1.14e-05	0.000273	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FGF1—melanoma	1.14e-05	0.000272	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CSF2—melanoma	1.14e-05	0.000272	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—IL2—melanoma	1.12e-05	0.000268	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP17A1—melanoma	1.12e-05	0.000267	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—E2F1—melanoma	1.11e-05	0.000266	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PIK3CB—melanoma	1.11e-05	0.000265	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SDHD—melanoma	1.1e-05	0.000263	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CSPG4—melanoma	1.1e-05	0.000263	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—BSG—melanoma	1.1e-05	0.000263	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PDGFRA—melanoma	1.1e-05	0.000263	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ITGB3—melanoma	1.09e-05	0.00026	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PRKCA—melanoma	1.09e-05	0.00026	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—SPP1—melanoma	1.07e-05	0.000255	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GPAM—melanoma	1.07e-05	0.000255	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MAP2K2—melanoma	1.07e-05	0.000255	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CXCL8—melanoma	1.07e-05	0.000254	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GNA11—melanoma	1.06e-05	0.000252	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP17A1—melanoma	1.05e-05	0.000251	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.03e-05	0.000247	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—FASN—melanoma	1.03e-05	0.000247	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—IL2—melanoma	1.02e-05	0.000243	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—SLC5A5—melanoma	1.02e-05	0.000243	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TERT—melanoma	1.01e-05	0.000242	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—RAC1—melanoma	1.01e-05	0.000241	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GNA11—melanoma	9.95e-06	0.000237	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—GNAQ—melanoma	9.81e-06	0.000234	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CD44—melanoma	9.81e-06	0.000234	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—FASN—melanoma	9.73e-06	0.000232	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HIF1A—melanoma	9.7e-06	0.000232	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—SLC5A5—melanoma	9.57e-06	0.000229	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CYP1B1—melanoma	9.41e-06	0.000225	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—KDR—melanoma	9.28e-06	0.000221	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—GNAQ—melanoma	9.25e-06	0.000221	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CD44—melanoma	9.25e-06	0.000221	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PLA2G6—melanoma	9.09e-06	0.000217	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FN1—melanoma	8.93e-06	0.000213	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CYP1B1—melanoma	8.86e-06	0.000212	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NOTCH1—melanoma	8.74e-06	0.000209	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CD80—melanoma	8.56e-06	0.000204	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—APC—melanoma	8.55e-06	0.000204	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PIK3CG—melanoma	8.55e-06	0.000204	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—KIT—melanoma	8.55e-06	0.000204	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—NRAS—melanoma	8.55e-06	0.000204	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—EGF—melanoma	8.45e-06	0.000202	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—MAPK3—melanoma	8.19e-06	0.000195	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—VCAN—melanoma	8.16e-06	0.000195	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—BRAF—melanoma	8.03e-06	0.000192	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IGF1—melanoma	7.83e-06	0.000187	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—MAPK1—melanoma	7.79e-06	0.000186	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—EGFR—melanoma	7.79e-06	0.000186	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MAP2K1—melanoma	7.56e-06	0.000181	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PIK3CD—melanoma	7.51e-06	0.000179	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—PIK3CA—melanoma	7.44e-06	0.000178	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—KRAS—melanoma	7.36e-06	0.000176	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ABCB1—melanoma	7.3e-06	0.000174	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—FGF2—melanoma	7.19e-06	0.000172	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PRKCA—melanoma	7.13e-06	0.00017	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ERCC2—melanoma	7.07e-06	0.000169	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP17A1—melanoma	6.89e-06	0.000164	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—PIK3CA—melanoma	6.76e-06	0.000161	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MDM2—melanoma	6.73e-06	0.000161	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PRKCA—melanoma	6.72e-06	0.00016	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ERCC2—melanoma	6.66e-06	0.000159	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ERBB2—melanoma	6.64e-06	0.000158	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PIK3CB—melanoma	6.55e-06	0.000156	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GNA11—melanoma	6.5e-06	0.000155	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—FASN—melanoma	6.36e-06	0.000152	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CXCL8—melanoma	6.29e-06	0.00015	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—SLC5A5—melanoma	6.26e-06	0.000149	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HRAS—melanoma	6.25e-06	0.000149	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CDKN1B—melanoma	6.15e-06	0.000147	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—AKT1—melanoma	6.08e-06	0.000145	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—GNAQ—melanoma	6.05e-06	0.000144	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CD44—melanoma	6.05e-06	0.000144	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CASP3—melanoma	6.02e-06	0.000144	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IL2—melanoma	6.01e-06	0.000144	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—IL6—melanoma	5.98e-06	0.000143	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CCND1—melanoma	5.86e-06	0.00014	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CTNNB1—melanoma	5.81e-06	0.000139	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CYP1B1—melanoma	5.8e-06	0.000138	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MMP9—melanoma	5.69e-06	0.000136	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CDKN1A—melanoma	5.67e-06	0.000135	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PTEN—melanoma	5.66e-06	0.000135	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NFKB1—melanoma	5.63e-06	0.000134	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3CG—melanoma	5.58e-06	0.000133	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—AKT1—melanoma	5.52e-06	0.000132	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PPARG—melanoma	5.39e-06	0.000129	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3CG—melanoma	5.26e-06	0.000126	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—VEGFA—melanoma	5.11e-06	0.000122	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PPARG—melanoma	5.08e-06	0.000121	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—STAT3—melanoma	5.06e-06	0.000121	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NRAS—melanoma	5.05e-06	0.000121	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3CD—melanoma	4.91e-06	0.000117	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—ALB—melanoma	4.85e-06	0.000116	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MAPK3—melanoma	4.84e-06	0.000115	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ABCB1—melanoma	4.77e-06	0.000114	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MYC—melanoma	4.7e-06	0.000112	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3CD—melanoma	4.63e-06	0.00011	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—MAPK1—melanoma	4.6e-06	0.00011	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—EGFR—melanoma	4.6e-06	0.00011	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—ALB—melanoma	4.57e-06	0.000109	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PRKCA—melanoma	4.39e-06	0.000105	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ERCC2—melanoma	4.36e-06	0.000104	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—KRAS—melanoma	4.35e-06	0.000104	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3CB—melanoma	4.28e-06	0.000102	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PTGS2—melanoma	4.24e-06	0.000101	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3CB—melanoma	4.03e-06	9.63e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PTGS2—melanoma	4e-06	9.54e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PIK3CA—melanoma	3.99e-06	9.53e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TP53—melanoma	3.86e-06	9.22e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PTEN—melanoma	3.7e-06	8.83e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HRAS—melanoma	3.69e-06	8.82e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—IL6—melanoma	3.54e-06	8.44e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PTEN—melanoma	3.48e-06	8.32e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3CG—melanoma	3.44e-06	8.21e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PPARG—melanoma	3.32e-06	7.93e-05	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—AKT1—melanoma	3.26e-06	7.79e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3CD—melanoma	3.02e-06	7.22e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—ALB—melanoma	2.99e-06	7.13e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3CB—melanoma	2.64e-06	6.29e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PTGS2—melanoma	2.61e-06	6.24e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—PIK3CA—melanoma	2.61e-06	6.23e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—PIK3CA—melanoma	2.46e-06	5.87e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PTEN—melanoma	2.28e-06	5.44e-05	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—AKT1—melanoma	2.13e-06	5.09e-05	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—AKT1—melanoma	2.01e-06	4.79e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—PIK3CA—melanoma	1.61e-06	3.84e-05	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—AKT1—melanoma	1.31e-06	3.13e-05	CbGpPWpGaD
